Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
855-907-3286Clinical.Trials@bms.comFirst line of the email MUST contain NCT # and Site #.
CONTACT
Lead Sponsor
Bristol-Myers Squibb
NCT07361497 · Non-small Cell Lung Cancer (NSCLC)
NCT07510724 · Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and more
NCT06726720 · Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
NCT06305754 · Non-small Cell Lung Cancer (NSCLC)
NCT07130786 · Seizures, Primary Motor Cortex, and more
USC/Norris Comprehensive Cancer Center
Los Angeles, California
Valkyrie Clinical Trials
Los Angeles, California
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions